Literature DB >> 25015979

Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study.

Cristiana Cipriani1, Vincenzo Carnevale2, Federica Biamonte2, Sara Piemonte2, Jessica Pepe2, Luciano Nieddu2, John P Bilezikian2, Salvatore Minisola2.   

Abstract

OBJECTIVE: Primary hyperparathyroidism (PHPT) is one of the most frequently diagnosed endocrine disorders, but few studies have focused on hospital management of the disease in Europe. We investigated the frequency of hospital admission for diagnosis and surgical treatment of PHPT in Italy.
DESIGN: A retrospective study was conducted for investigating the hospital care for PHPT in Italy.
METHODS: We retrieved data from the 'Record of Hospital Discharge' of the Italian Health Ministry, from 2006 to 2011, and analyzed the codes corresponding to PHPT-related diagnoses and surgical procedures.
RESULTS: Overall, 46 275 hospitalization episodes for PHPT were identified during the entire period (69% in women and 31% in men; mean age 63.3±39.8 years). Patients' mean age significantly increased during the years (P<0.001). The mean length of stay was 8.2±10.5 days (28% of the episodes requiring <3 days of stay). Admissions for surgical procedures were 12 457 accounting for 26.9% of the total hospitalizations. There was a trend to a significant increase in the percentage of surgery (P<0.05). The mean hospitalization rate for PHPT was 12.9/100 000 inhabitants per year and the trend showed a significant decrease during the period of 2006-2011 (P<0.0001). The mean hospitalization rate for PHPT surgery was 3.65/100 000 per year, which significantly increased over time (P<0.001).
CONCLUSIONS: PHPT considerably influences the Italian Hospital healthcare system. We observed a tendency to a decrease in the frequency of hospitalization during the period of 2006-2011, most probably because of economic issues, a concomitant increased age of patients, and, interestingly, also a progressive increase in the percentage of surgical treatment among patients admitted for PHPT.
© 2014 European Society of Endocrinology.

Entities:  

Mesh:

Year:  2014        PMID: 25015979      PMCID: PMC4319661          DOI: 10.1530/EJE-14-0493

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  The risk of fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Simona De Geronimo; Elisabetta Romagnoli; Daniele Diacinti; Emilio D'Erasmo; Salvatore Minisola
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

2.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

3.  Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.

Authors:  Charlotte L Mollerup; Peter Vestergaard; Vibe Gedsø Frøkjaer; Leif Mosekilde; Peer Christiansen; Mogens Blichert-Toft
Journal:  BMJ       Date:  2002-10-12

4.  Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease.

Authors:  Robert A Wermers; Sundeep Khosla; Elizabeth J Atkinson; Sara J Achenbach; Ann L Oberg; Clive S Grant; L Joseph Melton
Journal:  J Bone Miner Res       Date:  2005-09-19       Impact factor: 6.741

5.  The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

Authors:  R A Wermers; S Khosla; E J Atkinson; S F Hodgson; W M O'Fallon; L J Melton
Journal:  Ann Intern Med       Date:  1997-03-15       Impact factor: 25.391

6.  Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.

Authors:  Laura Richert; Andrea Trombetti; François R Herrmann; Frédéric Triponez; Christian Meier; John H Robert; René Rizzoli
Journal:  Swiss Med Wkly       Date:  2009-07-11       Impact factor: 2.193

7.  Screening for multiple endocrine neoplasia syndrome (type 1) in patients with primary hyperparathyroidism.

Authors:  C Muhr; S Ljunghall; G Akerstrom; M Palmér; K Bergström; P Enoksson; G Lundqvist; L Wide
Journal:  Clin Endocrinol (Oxf)       Date:  1984-02       Impact factor: 3.478

8.  Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK.

Authors:  Ning Yu; Peter T Donnan; Michael J Murphy; Graham P Leese
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10       Impact factor: 3.478

9.  Skeletal disease in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; L de la Cruz; D W Dempster; F Feldman; D Seldin; T P Jacobs; E S Siris; M Cafferty; M V Parisien
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

Review 10.  Parathyroid carcinoma.

Authors:  Claudio Marcocci; Filomena Cetani; Mishaela R Rubin; Shonni J Silverberg; Aldo Pinchera; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

View more
  3 in total

1.  Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

Authors:  Cristiana Cipriani; Federica Biamonte; Aline G Costa; Chiyuan Zhang; Piergianni Biondi; Daniele Diacinti; Jessica Pepe; Sara Piemonte; Alfredo Scillitani; Salvatore Minisola; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2015-02-03       Impact factor: 5.958

2.  Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Authors:  F Saponaro; F Cetani; A Repaci; U Pagotto; C Cipriani; J Pepe; S Minisola; C Cipri; F Vescini; A Scillitani; A Salcuni; S Palmieri; C Eller-Vainicher; I Chiodini; B Madeo; E Kara; E Castellano; G Borretta; L Gianotti; F Romanelli; V Camozzi; A Faggiano; S Corbetta; L Cianferotti; M L Brandi; M L De Feo; A Palermo; G Vezzoli; F Maino; M Scalese; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-04-03       Impact factor: 4.256

Review 3.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.